Zoledronic Acid
Product Images NDC 17478-327

4 FDA label images from Akorn · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Zoledronic Acid (NDC 17478-327). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Akorn, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Zol0h 0007 01)

Structural Formula (Zol0h 0007 01)
Chemical structure of zoledronic acid monohydrate, showing its bisphosphonate moiety bonded to an imidazole ring and three water molecules of hydration.*
FDA Label Image

Figure 1 (Zol0h 0007 02)

Figure 1 (Zol0h 0007 02)
A bar chart titled 'Proportion of Complete Responders by Day 10 in Pooled HCM Studies' comparing Zoledronic Acid Injection 4 mg (n=86) and Pamidronate 90 mg (n=99). The chart shows the percentage of complete responders, with Zoledronic Acid reaching around 90% and Pamidronate around 60%, with a p-value of 0.002 indicating statistical significance.*
FDA Label Image

Principal Display Panel – 5 mL Vial Label (Zol0h 0007 03)

Principal Display Panel – 5 mL Vial Label (Zol0h 0007 03)
Label for Zoledronic Acid Injection 4 mg/5 mL (0.8 mg/mL) sterile concentrate for intravenous infusion after dilution by Akorn. The 5 mL single-dose vial label includes storage instructions, dosing restriction, manufacturer details (Fresenius Kabi Austria GmbH), and a barcode.*
FDA Label Image

Principal Display Panel – 5 mL Carton Label (Zol0h 0007 04)

Principal Display Panel – 5 mL Carton Label (Zol0h 0007 04)
Packaging label for Zoledronic Acid Injection 4 mg/5 mL (0.8 mg/mL) sterile concentrate for intravenous infusion after dilution. The label shows a 1 x 5 mL single-dose vial with instructions that the dose must be diluted and not directly injected. Manufactured by Akorn, with NDC 17478-327-05. Contains warnings about not mixing with calcium-containing infusion solutions and storage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.